Steven R. Goldstein

Steven R. Goldstein's AcademicInfluence.com Rankings

Steven R. Goldstein

Economics

#3765

World Rank

#4259

Historical Rank

#1067

USA Rank

Monetary Economics

#124

World Rank

#128

Historical Rank

#43

USA Rank

Macroeconomics

#371

World Rank

#396

Historical Rank

#118

USA Rank

economics Degrees

Download Badge

Economics

Why Is Steven R. Goldstein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Steven R. Goldstein is an inventor, author and a professor of obstetrics and gynecology at NYU School of Medicine. He is the director of NYU’s Gynecological Ultrasound and the co-director of the Bone Densitometry and Body Composition Unit.

(See a Problem?)

Steven R. Goldstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society (2013) (485)
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group (2015) (363)
Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. (1990) (300)
Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. (2010) (258)
Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. (2011) (242)
Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group (2010) (211)
Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding. (1997) (207)
A pharmacological review of selective oestrogen receptor modulators. (2000) (189)
Evaluation of the Woman With Postmenopausal Bleeding: Society of Radiologists in Ultrasound–Sponsored Consensus Conference Statement (2002) (188)
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. (2019) (168)
Lasofoxifene in postmenopausal women with osteoporosis. (2010) (156)
Use of ultrasonohysterography for triage of perimenopausal patients with unexplained uterine bleeding. (1994) (150)
Evaluation of endometrial polyps. (2002) (139)
A 12‐Month Comparative Study of Raloxifene, Estrogen, and Placebo on the Postmenopausal Endometrium (2000) (138)
Diagnostic criteria for nonviable pregnancy early in the first trimester. (2013) (137)
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. (2002) (121)
Modern evaluation of the endometrium. (2010) (119)
Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement. (2010) (116)
Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy (2013) (111)
Very Early Pregnancy Detection With Endovaginal Ultrasound (1988) (105)
Pregnancies of unknown location: consensus statement (2006) (104)
Embryonic Death in Early Pregnancy: A New Look at the First Trimester (1994) (102)
Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. (1994) (100)
Endovaginal ultrasonographic measurement of early embryonic size as a means of assessing gestational age. (1994) (96)
Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors (2019) (87)
Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee. (2018) (85)
The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium. (2009) (84)
Significance of Cardiac Activity on Endovaginal Ultrasound in Very Early Embryos (1992) (81)
Abnormal uterine bleeding in perimenopause (2017) (80)
Raloxifene Effect on Frequency of Surgery for Pelvic Floor Relaxation (2001) (76)
First International Consensus Report on Adnexal Masses: Management Recommendations (2017) (76)
Postmenopausal Endometrial Fluid Collections Revisited: Look at the Doughnut Rather Than the Hole (1994) (72)
Estimation of Nongravid Uterine Volume Based on a Nomogram of Gravid Uterine Volume: Its Value in Gynecologic Uterine Abnormalities (1988) (69)
Bayesian comparison of cost-effectiveness of different clinical approaches to diagnose coronary artery disease. (1984) (66)
Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen (1994) (63)
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society (2015) (61)
Endometrial safety: a key hurdle for selective estrogen receptor modulators in development (2010) (61)
Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes (2011) (57)
Why the product labeling for low-dose vaginal estrogen should be changed (2014) (57)
Embryonic ultrasonographic measurements: crown-rump length revisited. (1991) (57)
Menorrhagia and abnormal bleeding before the menopause. (2004) (55)
Incorporating endovaginal ultrasonography into the overall gynecologic examination. (1990) (55)
An evidence‐based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis (2018) (53)
Saline infusion sonohysterography. (1996) (52)
Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen (2005) (50)
Subchorionic bleeding in threatened abortion: sonographic findings and significance. (1983) (49)
The Effect of SERMs on the Endometrium (2001) (47)
Consider ultrasound first for imaging the female pelvis. (2015) (47)
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program (2015) (38)
Alterations in steroid hormone receptors in the tamoxifen-treated endometrium (1997) (37)
Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting. (2019) (36)
Raloxifene use in clinical practice: efficacy and safety (2009) (36)
Transrectal scanning: an alternative when transvaginal scanning is not feasible (2003) (35)
Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial (2019) (33)
The endometrial echo revisited: have we created a monster? (2004) (33)
Postmenopausal adnexal cysts: how clinical management has evolved. (1996) (32)
Early detection of pathologic pregnancy by transvaginal sonography (1990) (32)
Electrical impedance scanning as a new breast cancer risk stratification tool for young women (2008) (32)
The Complexity of a “Complex Mass” and the Simplicity of a “Simple Cyst” (2005) (30)
Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women. (1998) (27)
ACOG technology assessment in obstetrics and gynecology. Number 3, September 2003. Saline infusion sonohysterography. (2003) (24)
Update on raloxifene to prevent endometrial-breast cancer. (2000) (23)
Begin With the Basics (2013) (22)
Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study (2002) (22)
An Updated Protocol for Abortion Surveillance With Ultrasound and Immediate Pathology (1994) (20)
Controversy about uterine effects and safety of SERMs: the saga continues. (2002) (19)
Significance of incidentally thick endometrial echo on transvaginal ultrasound in postmenopausal women (2011) (18)
Transvaginal ultrasound-assisted gynecologic surgery: evaluation of a new device to improve safety of intrauterine surgery. (2003) (18)
Abnormal Uterine Bleeding. (2019) (17)
Alterations in steroid hormone receptors in the tamoxifen-treated endometrium. (1998) (17)
Osteoporosis risk factors and early life-style modifications to decrease disease burden in women. (2013) (17)
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review (2019) (16)
Abnormal uterine bleeding: the role of ultrasound. (2006) (16)
Does the Use of Postmenopausal Hormone Replacement Therapy Influence the Size of Uterine Leiomyomata? A Preliminary Report (1996) (15)
The effect of raloxifene on the incidence of ovarian cancer in postmenopausal women. (2002) (15)
Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause (2019) (13)
Office Diagnosis and Management of Abnormal Uterine Bleeding (2012) (13)
Cystadenofibromas: Can transvaginal ultrasound appearance reduce some surgical interventions? (2015) (13)
Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system? (2015) (13)
Ultrasound in Gynecology (1995) (13)
Conservative Management of Small Postmenopausal Cystic Masses (1993) (12)
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass (2012) (12)
Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health. (1999) (12)
Sonography in Early Pregnancy Failure (1994) (12)
AIUM Practice Guideline for Ultrasonography in Reproductive Medicine (2009) (12)
NICE guidance on ectopic pregnancy and miscarriage restricts access and choice and may be clinically unsafe (2013) (12)
Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR)∗ (2020) (12)
Early pregnancy: normal and abnormal. (2008) (11)
Transvaginal Ultrasound for the Diagnosis of Abnormal Uterine Bleeding (2017) (11)
International survey finds majority of gynecologists are not aware of and do not utilize ultrasound techniques to diagnose and map endometriosis (2020) (11)
Transcutaneous Nerve Stimulation for Pain Relief During Office Hysteroscopy: A Randomized Controlled Trial. (2017) (10)
The routine use of ultrasound in the gynecological visit (1996) (10)
Hematosalpinx in tubal pregnancy: sonographic-pathologic correlation. (1983) (10)
Selective estrogen receptor modulators and bone health (2021) (10)
Early Pregnancy Failure (2003) (9)
Still another selective estrogen receptor modulator to enhance women's health: this time in combination with conjugated equine estrogens. (2014) (9)
Skin, hair and beyond: the impact of menopause (2022) (9)
Drugs for the gynecologist to prescribe in the prevention of breast cancer: current status and future trends. (2000) (9)
Postmenopausal dyspareunia: has the Food and Drug Administration really helped? (2013) (9)
Accreditation, certification: why all the confusion? (2007) (9)
Sonography in Postmenopausal Bleeding (2012) (8)
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene (2016) (8)
P-71. Effects of Raloxifene on the Endometrium in Healthy Postmenopausal Women (1997) (8)
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative (2021) (8)
Transvaginal sonographic technique: Targeted organ scanning without resorting to “planes” (1990) (7)
Clinical Assessment and Ultrasound in Early Pregnancy (2009) (7)
Endometrial Safety of Ospemifene and the Ability of Transvaginal Ultrasonography to Detect Small Changes in Endometrial Thickness (2014) (7)
Effect of SERMs on breast tissue (1999) (7)
S-12.: Uterine Safety Considerations for Selective Estrogen Receptor Modulators (1997) (7)
Evaluation of Abnormal Vaginal Bleeding in Perimenopausal Women with Endovaginal Ultrasound and Saline Infusion Sonohysterography (1997) (7)
The presence of endometrial fluid in asymptomatic postmenopausal women is associated with clinically relevant cervical stenosis (1997) (7)
Endometrial safety during hormone replacement therapy: comparison of transvaginal sonography and endometrial biopsy. (1998) (7)
Routine Use of Office Gynecologic Ultrasound (2002) (7)
P-70. Quantitative Ultrasound of the Calcaneus: Comparison with Dual Emission X-ray Absorptiometry (DEXA) of the Hip (1998) (7)
Appropriate evaluation of postmenopausal bleeding. (2018) (6)
Bone health 2022: an update (2022) (6)
Not all selective estrogen response modulators are created equal: update on lasofoxifene. (2006) (6)
The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key? (2005) (6)
Uterine bleeding with hormone therapies in menopausal women: a systematic review (2020) (6)
Evaluation of the Woman With Postmenopausal Bleeding (2002) (6)
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative (2021) (6)
Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms (2020) (5)
Ratio of gestational sac volume to crown-rump length in early pregnancy. (1986) (5)
An update on non-uterine gynaecological effects on raloxifene. (2002) (5)
Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data (2019) (5)
Effect of raloxifene on the endometrium: will this be the ultimate key to its utilization? (1999) (4)
TERMS AND DEFINITIONS FOR DESCRIBING MYOMETRIAL PATHOLOGY USING ULTRASONOGRAPHY (2016) (4)
Combined Sonographic-Pathologic Surveillance in Elective First-Trimester Termination of Pregnancy (1988) (4)
Update on bone health: the International Menopause Society White Paper 2021 (2021) (3)
Use of endovaginal ultrasound in the overall gynecologic examination. (1991) (3)
Ability to successfully image endometrium on transvaginal ultrasound in asymptomatic postmenopausal women (2021) (3)
Early pregnancy failure--appropriate terminology. (1990) (3)
Increased Incidence of Endometrial Cancer Following the WHI: An Assessment of Risk Factors [18OP] (2017) (3)
The conundrum of asymptomatic adnexal masses: a clinician's opinion. (2016) (3)
Integrating complementary medicine into veterinary practice (2008) (2)
Reprocessing of the vaginal probe between patients (1996) (2)
90258939 Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding (1991) (2)
Further attempts to refine our diagnostic capabilities in potential ectopic pregnancies (1999) (2)
The Sound Judgment Series (2012) (2)
Predicting uterine weight before hysterectomy: ultrasound measurements vs clinical assessment. (2007) (1)
2020 Update on bone health (2020) (1)
Textbook of perimenopausal gynecology (2003) (1)
Selective estrogen receptor modulator: the saga continues. (2010) (1)
Screening and Monitoring Endometrial Response to Tamoxifen Therapy for Breast Cancer: S-l. (1996) (1)
EVALUATING THE ENDOMETRIUM IN WOMEN ON TAMOXIFEN (1997) (1)
Ultrasound-based triage for abnormal uterine bleeding (2003) (1)
Increasing use of gynecolog ic ultrasonog raphy (1992) (1)
Imaging of the infertile couple (2001) (1)
SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms (2019) (1)
Pelvic Imaging in Reproductive Endocrinology (2019) (1)
Immediate impression of the utility of transesophageal echo is confirmed at follow-up: V.O.T.E. II study (1996) (1)
Ultrasound scanning in reproductive medicine and infertility. Preface. (2008) (0)
RAPID COMMUNICATION The Effect of Raloxifene on the Incidence of Ovarian Cancer in Postmenopausal Women 1 (2002) (0)
Bone health medications: research questions versus clinical choices. (2011) (0)
Wide variation in institutional transesophageal echo utilization affects its apparent value: From V.O.T.E. I (1996) (0)
Sign Out: If it ain't broke, why are we fixing it? (2007) (0)
Ovarian conservation at the time of hysterectomy for benign disease: where is the pendulum now? (2014) (0)
Letter to the editor. (2015) (0)
Vaginal Progesterone in Hormone Replacement Therapy (HRT): Experience With the Vaginal Gel Crinone 4% in Peri- and Post-menopausal Women: P-126. (1999) (0)
Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306 (2022) (0)
Potential Impact of Emerging Therapies on Osteoporosis Prevention (1998) (0)
Can We Diagnose Early Endometriosis with Ultrasound Rather than Laparoscopy? (2020) (0)
Office Ultrasonography of the Pelvis (1993) (0)
A bone health expert considers recent evidence on osteosarcopenia as a risk factor , consequences of delayed denosumab dosing , bisphosphonates and atypical femur fracture , and the T-score as a treatment target in a romosozumab study (2020) (0)
Raloxifene vs tamoxifen. Authors' reply (2007) (0)
INDIVIDUALIZING HRT WITH LOWER DOSE REGIMENS : CLINICAL TRIAL REVIEW : MENOPAUSAL SYMPTOMS AND BLEEDING PROFILE (2015) (0)
The value of transesophageal echo II study: Findings of study I and design of study II (1995) (0)
First InternationalConsensusReporton AdnexalMasses ManagementRecommendations (2017) (0)
Selective Estrogen Receptor Modulators (SERMs) and Menopausal Hormone Therapy (MHT) (2020) (0)
Benign Endometrial Changes by Race and BMI With Ulipristal Acetate Treatment: 51 (2018) (0)
Introduction to a special section on the causality, diagnosis, and management of abnormal uterine bleeding. (2011) (0)
0474: A Systematic Approach to Abnormal Uterine Bleeding. Saline Infusion Sonohysterography or Outpatient Endometrial Pipelle Biopsy? (2009) (0)
Increasing use of gynecologic ultrasonography. (1992) (0)
Gynecologic Teleultrasound and COVID‐19 (2022) (0)
Endometrial changes assessed by transvaginal sonography (1998) (0)
OC10.01: The endometrial echo revisited: have we created a monster? (2005) (0)
Ultrasonographic evaluation of patients with abnormal bleeding. (1995) (0)
Ultrasound in Gynecology: Development and Continuing Evolution (2007) (0)
It takes a big man to admit he's wrong (2012) (0)
Diagnosing abnormal uterine bleeding in perimenopausal women (2003) (0)
Endometrial Evaluation : Are You Still Relying on a Blind Biopsy ? (2017) (0)
Ultrasound-Enhanced Bimanual Examination (2007) (0)
OC08.06: Ability to adequately visualise an endometrial echo on transvaginal ultrasound in asymptomatic postmenopausal women (2019) (0)
TUAGS (transvaginal ultrasound assisted gynecological surgery): a new technique to improve uterine surgery (2003) (0)
Endometrial histology of a novel HRT regimen (2000) (0)
Transvaginal sonographic detection of the pseudogestational sac associated with ectopic pregnancy. (1990) (0)
Reaffirming microcystic ultrasound appearance of borderline ovarian tumors using three‐dimensional ‘silhouette’ rendering (2022) (0)
Chapter 37 – Gynecologic Management of the Woman with Breast Cancer (2005) (0)
Reply (2022) (0)
Ultrasound in menopause: a look back. (2018) (0)
Sign Out: Seeing is believing (2005) (0)
of myometrium and uterine masses : a consensus opinion from the Morphological Uterus (2018) (0)
Intrauterine Ultrasound: A New Imaging Modality for Intramyometrial Pathology (2009) (0)
0476: Significance of Incidental Ultrasound Findings in Post-Menopausal Women, to Remove or Not to Remove? (2009) (0)
Menopausal Dilemmas: How Ultrasound Has Changed Clinical Management (2007) (0)
Attempt to reduce the progestogen component in hormone therapy. (2006) (0)
Sarcopenic obesity: a double whammy. (2022) (0)
DHEA lowers abdominal fat , improves insulin action in older postmenopausal women (0)
ULTRASONOGRAPHIC EVALUATION OF PATIENTS WITH ABNORMAL BLEEDING. AUTHORS' REPLY (1995) (0)
OC132: Abnormal uterine bleeding: using ultrasound to avoid unnecessary intervention (2004) (0)
1829 Current State of Pelvic Ultrasound for Endometriosis: Results of an International Survey (2019) (0)
OP14.01: Current state of pelvic ultrasound for endometriosis: results of an international survey (2019) (0)
Pearls and Pitfalls of Transvaginal Sonography (2007) (0)
P3.13.24 The effect of raloxifene on the incidence of surgical intervention for pelvic floor relaxation (2000) (0)
P-62.: The Effects of Tamoxifen on Uterine Leiomyoma Size and Ovarian Cyst Formation (1997) (0)
Vaginal probe ultrasonography and ectopic pregnancy. (1990) (0)
Steven R. Goldstein, MD, FACOG, CCD, NCMP. 2010-2011 NAMS President. (2010) (0)
1021-54 Multiplane Transesophageal Echo Has a Greater Impact on Clinical Care than Biplane: The VOTE Study (1995) (0)
Not all SERMs are created equal: chapter 2. (2015) (0)
Reply (2010) (0)
094 Phase III Study Evaluating Efficacy and Safety of Ospemifene in Menopausal Women with Moderate to Severe Vaginal Dryness: Overall Patient Satisfaction with Treatment (2019) (0)
The Use of Ultrasound in the Perimenopausal Patient (2018) (0)
20.: Ultrasound Based Triage of Women with Abnormal Uterine Bleeding (1997) (0)
Vaginal Ultrasound Evaluation of Early Pregnancy (1993) (0)
To the editor. Use of transvaginal ultrasonography and sonohysterography. (2008) (0)
The effects of selective estrogen receptor modulators on the endometrium (2020) (0)
Modern evaluation of abnormal uterine bleeding (2019) (0)
Assessment of Endometrial Safety During Treatment of Symptomatic Uterine Fibroids With Ulipristal Acetate: VENUS II (2018) (0)
Can US “pattern recognition” of classic adnexal lesions reduce surgery, and even referrals for other imaging, in average-risk women? (2022) (0)
The IMS: charting a course forward (2020) (0)
POSTMENOPAUSAL EVALUATION AND RISK-REDUCTION WITH LASOFOXIFENE (THE PEARL TRIAL): GYNAECOLOGICAL OUTCOMES AT FIVE-YEARS (2009) (0)
Menopause and HRT (2018) (0)
For those intolerant to ACE inhibitors and ARBs , what is the best therapy for reducing the risk of diabetic nephropathy ? (0)
Diagnosing Abnormal Uterine Bleeding: The Standard of Care Has Changed (2019) (0)
Raloxifene vs tamoxifen. (2007) (0)
0522: Post Menopausal Bleeding. How Reliable is Transvaginal Ultrasound in Excluding Endometrial Cancer? (2009) (0)
Is Percentile Body Fat by Dual-Energy X-Ray Absorptiometry a Better Surrogate for Metabolic Health Than Body Mass Index? [308] (2015) (0)
Presidential reflections: how we got here, where we might go. (2023) (0)
Can a once-daily oral formulation treat symptoms of uterine fibroids without causing hot flashes or bone loss? (2021) (0)
Letter to the editor in response to "omissions, biases, and nondisclosed conflicts of interest: Is there a hidden agenda in the NAMS position statement?" (2005) (0)

This paper list is powered by the following services:

Other Resources About Steven R. Goldstein

en.wikipedia.org

What Schools Are Affiliated With Steven R. Goldstein?

Steven R. Goldstein is affiliated with the following schools:

Steven R. Goldstein's Academic­Influence.com Rankings

Why Is Steven R. Goldstein Influential?

Steven R. Goldstein's Published Works

Published Works

Other Resources About Steven R. Goldstein

What Schools Are Affiliated With Steven R. Goldstein?

Steven R. Goldstein's AcademicInfluence.com Rankings